Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2026-09-04)

USD 18.45-1.39%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

5.00 2 votes No rating yet

NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo K.K. is a Japanese pharmaceutical manufacturer that develops, produces and markets medicines and related chemical intermediates for healthcare markets, supplying hospitals, pharmacies and distributors at home and abroad. Its business combines research and formulation work with commercial manufacturing—covering active pharmaceutical ingredient production, finished‑dose formulation, quality control and regulatory compliance—and it also provides contract manufacturing and outsourcing services to other drugmakers. The company’s product mix spans prescription (ethical) medicines, consumer health/OTC products and bulk pharmaceutical ingredients, with operations organized to support manufacturing scale, supply‑chain reliability and customer distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

20.7%1Y

19.9%3Y

8.72%5Y

Performance

20.7%1Y

20.0%3Y

20.0%5Y

Volatility

58313 M

Market cap (USD)

1,499,547

Daily traded volume (Shares)

13.25 / 13.155

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

2 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Adam Hakimi Bin Hasni

UK, 04 Nov 2025

A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan

sofia nava

Switzerland, 29 Oct 2025

.

EQUITIES OF THE SAME SECTOR

Siegfried Holding Ltd

Siegfried Holding Ltd Valor: 1428449

Annual Return

-50%0%+50%

Risk level

110

-0.35%CHF 70.50

Mankind Pharma Ltd.

Mankind Pharma Ltd. Valor: 126566338

Annual Return

-50%0%+50%

Risk level

110

-0.70%INR 2,328.55

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

-0.33%SEK 272.20

Lifco Ab

Lifco Ab Valor: 111355378

Annual Return

-50%0%+50%

Risk level

110

-0.38%SEK 314.20

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Valor: 2676862

Annual Return

-50%0%+50%

Risk level

110

-1.13%SEK 454.80

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc Valor: 22860122

Annual Return

-50%0%+50%

Risk level

110

3.03%USD 15.30

Baxter International Inc

Baxter International Inc Valor: 911702

Annual Return

-50%0%+50%

Risk level

110

1.02%USD 25.83

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

0.35%GBP 25.85

Vitrolife AB

Vitrolife AB Valor: 41707777

Annual Return

-50%0%+50%

Risk level

110

-1.50%SEK 95.00

Elekta AB

Elekta AB Valor: 613625

Annual Return

-50%0%+50%

Risk level

110

-1.32%SEK 52.30

SIX

FactSet

Clearbit

Logos provided by Clearbit